Allinky presents its inflammation program at AseBio Investor Day in San Sebastián

AseBio Investor Day is a key event that gathers prominent figures from the biotechnology and investment communities, fostering collaboration and showcasing innovative projects.

At the 2024 edition, which took place on May 15th in San Sebastián, Allinky had the opportunity to present its cutting-edge inflammation program to a select audience of national and international investors. This event, a cornerstone for biotech innovation and investment, provided an ideal platform for us to showcase our advancements and future plans in the field of chronic inflammation treatment.

Participating in this event not only underscores the credibility and potential of our work but also opens doors for new funding opportunities and strategic partnerships.